Currently out of the existing stock ratings of Christopher Liu, 7 are a BUY (100%).

Christopher Liu

Work Performance Price Targets & Ratings Chart

Analyst Christopher Liu works at LEERINK with a stock forecast success ratio of 16.67% fulfilled within 22.67 days on average.

Christopher Liu’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on COGT, Cogent Biosciences at 10-Jun-2022.

Wall Street Analyst Christopher Liu

Analyst best performing recommendations are on COGT (COGENT BIOSCIENCES).
The best stock recommendation documented was for COGT (COGENT BIOSCIENCES) at 6/10/2022. The price target of $15 was fulfilled within 68 days with a profit of $7.13 (90.6%) receiving and performance score of 13.32.

Average potential price target upside

COGT Cogent Biosciences NRIX Nurix Therapeutics  ARVN Arvinas

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

18

$10.51 (140.32%)

15

2 days ago

0/10 (0%)

$10.5 (140.00%)

Hold

10

$2.51 (33.51%)

5

5 days ago

2/5 (40%)

$2.56 (34.41%)

66

Buy

22

$14.51 (193.72%)

8 months 16 days ago

0/2 (0%)

$9.75 (79.59%)

Buy

20

$12.51 (167.02%)

18

1 years 1 months 23 days ago

1/3 (33.33%)

$8 (66.67%)

65

Buy

15

$7.51 (100.27%)

20

1 years 8 months 18 days ago

1/2 (50%)

$7.13 (90.60%)

68

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Christopher Liu?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?